SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgAuUSA who wrote (3)8/6/1996 11:46:00 PM
From: John Binford, Jr.   of 178
 
<< BEAM has reported excellent results in worldwide trials of its Apex Plus system to treat astigmatism and farsightedness. Currently 150+
Apex systems are in use in the US. >>

How is the Apex Plus treating astigmatism? Does it use the errodable mask?

As for my opinion of Summit, Muller needs to go. He has done nothing but shed a cloud over the whole industry.

As for Summit selling lasers, well I don't believe they are. They just layed off 55 people in Mass. (including the VP or R&D) who made the lasers here in the U.S. They can still make them in Ireland.

Visx's revenue (and record earnings) indicates that they are selling lasers and that their laser is the one of choice.

Summit, however, might be worth much more than they are currently trading for given the fact that their centers should eventually turn profitable and the fact that they get 44% of the PPP per procedure royalties.

Personally, I am long only on Visx and feel it is the best buy. Especially at the current price (Visx only has 1/2 the # of shares as Summit does).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext